Blog
RSS FeedPosted by Michael Wonder on 28 Oct 2018
PBAC Public Summary Documents - July 2018 meeting
26 October 2018 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the July 2018 PBAC ...
Posted by Michael Wonder on 31 Aug 2018
Pharma interactions educate and improve health outcomes
31 August 2018 - Medicines Australia is pleased to announce the release of the fifth biannual innovative medicines industry’s transfer ...
Posted by Michael Wonder on 22 Aug 2018
PBAC Drug Utilisation Sub-Committee utilisation analysis - public release documents
22 August 2018 - The utilisation analysis public release documents from the February 2018 DUSC meeting are now available. ...
Posted by Michael Wonder on 17 Aug 2018
Post-market review of the use of biologics in the treatment of severe chronic plaque psoriasis
17 August 2018 - The PBAC minutes pertaining to the draft review report for the post-market review of the use of ...
Posted by Michael Wonder on 30 Jul 2018
Health system neglects vulnerable Australians: Grattan Institute report
30 July 2018 - Vulnerable Australians are being neglected by a primary health system that is poorly integrated, lacks direction ...
Posted by Michael Wonder on 13 Jul 2018
Public Summary Documents – March 2018 PBAC meeting
13 July 2018 - The Public Summary Documents (first time rejections and deferrals) from the March 2018 PBAC meeting are now ...
Posted by Michael Wonder on 21 Jun 2018
Script for a healthier Australia: small steps and big savings
20 June 2018 - The latest Australia’s Health report provides persuasive evidence for a concerted national strategy to counter obesity ...
Posted by Michael Wonder on 21 May 2018
Draft report for the post-market review of medicines for pulmonary arterial hypertension
21 May 2018 - The draft report for the post-market review of medicines for pulmonary arterial hypertension is available for public ...
Posted by Michael Wonder on 27 Apr 2018
Public Summary Documents – December 2017 PBAC meeting
27 April 2018 - The Public Summary Documents (first time rejections and deferrals) from the December 2017 PBAC meeting are now ...
Posted by Michael Wonder on 19 Mar 2018
Outcome statement - Feb 2018 Drug Utilisation Sub Committee meeting
16 March 2018 - The outcome statement from the February 2018 Drug Utilisation Sub Committee meeting is now available. ...
Posted by Michael Wonder on 18 Mar 2018
Public Summary Documents - November 2017 PBAC meeting
16 March 2018 - The Public Summary Documents (first time rejections and deferrals) from the November 2017 PBAC meeting are now ...
Posted by Michael Wonder on 02 Mar 2018
PBAC Drug Utilisation Sub Committee utilisation analysis public release documents
2 March 2018 - The utilisation analysis public release documents from the September 2017 DUSC meeting are now available. ...
Posted by Michael Wonder on 23 Feb 2018
Nusinersen stakeholder meeting outcome statement
23 February 2018 - The outcome statement for the nusinersen stakeholder meeting held on 18 January 2018 is now available. ...
Posted by Michael Wonder on 30 Jan 2018
Post-market review of chronic obstructive pulmonary disease medicines – final report released
30 January 2018 - The final report and outcomes of the post-market review of chronic obstructive pulmonary disease medicines is now ...
Posted by Michael Wonder on 18 Jan 2018
Draft report for the post-market review of the use of biologics in the treatment of severe chronic plaque psoriasis
18 January 2018 - The draft report for the post-market review of the use of biologics in the treatment of severe ...